Bhawna Sama
Overview
Explore the profile of Bhawna Sama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sama B, Selisko B, Falcou C, Fattorini V, Piorkowski G, Touret F, et al.
Antiviral Res
. 2024 Nov;
232:106034.
PMID: 39510431
Remdesivir (RDV, Veklury®) is the first FDA-approved antiviral treatment for COVID-19. It is a nucleotide analogue (NA) carrying a 1'-cyano (1'-CN) group on the ribose and a pseudo-adenine nucleobase whose...
2.
Shannon A, Sama B, Gauffre P, Guez T, Debart F, Vasseur J, et al.
Nucleic Acids Res
. 2022 Oct;
50(19):11186-11198.
PMID: 36265859
The order Nidovirales is a diverse group of (+)RNA viruses, with a common genome organization and conserved set of replicative and editing enzymes. In particular, RNA methyltransferases play a central...
3.
Shannon A, Fattorini V, Sama B, Selisko B, Feracci M, Falcou C, et al.
Nat Commun
. 2022 Feb;
13(1):621.
PMID: 35110538
The guanosine analog AT-527 represents a promising candidate against Severe Acute Respiratory Syndrome coronavirus type 2 (SARS-CoV-2). AT-527 recently entered phase III clinical trials for the treatment of COVID-19. Once...
4.
Ferron F, Sama B, Decroly E, Canard B
Trends Biochem Sci
. 2021 Jun;
46(11):866-877.
PMID: 34172362
With sizes <50 kb, viral RNA genomes are at the crossroads of genetic, biophysical, and biochemical stability in their host cell. Here, we analyze the enzymatic assets accompanying large RNA...